NRAS and melanoma: Overall, NRAS mutations were detected in slightly less than a third (26.6%) of melanomas, and we found that NRAS mutations were much more frequent in melanomas of South Island patients (38.3%) than in North Island melanoma patients (21.9%), or in TCGA data (22%).